Willingness to participate in the study (consent to participate by patient or appropriate legal representative) or inclusion via deferred consent
Hospitalization at time of enrollment
Positive evidence for SARS-CoV-2 infection with PCR (polymerase chain reaction) or initial positive rapid diagnostic test in conjunction with typical clinical symptoms, confirmed by a later positive PCR test.
You may not be if
Refusal to participate by patient, or appropriate legal representative
Any condition that prohibits supplemental blood-sampling beyond routine blood drawing
